February 17, 2026
1 min read

Novartis taps Niowave for long-term supply of radiopharmaceutical isotope

The clamor for radioisotopes has continued into the new year, with Novartis inking a deal with radiopharmaceutical producer Niowave to supply the pharma giant with the specialized ingredient Actinium-225 (Ac-225) used to develop targeted cancer therapies.

Leave a Reply

Your email address will not be published.

Previous Story

Free Nutrition Counseling Sign-Up

Next Story

Abortion Restrictions Increase Deaths Among Expecting And New Moms, Researchers Report MedNews

Previous Story

Free Nutrition Counseling Sign-Up

Next Story

Abortion Restrictions Increase Deaths Among Expecting And New Moms, Researchers Report MedNews

Latest from Blog

NEWS CENTER Maine

Through in-depth storytelling, through direct contact on digital on social platforms, through long-standing community service programs like Coats & Toys for Kids, Project Heat and Buddy to Buddy, NEWS CENTER Maine is
Go toTop